SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-10-060202
Filing Date
2010-11-29
Accepted
2010-11-29 07:01:09
Documents
6
Period of Report
2010-11-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a10-21843_18k.htm 8-K 28403
2 EX-10.1 a10-21843_1ex10d1.htm EX-10.1 177162
3 EX-10.2 a10-21843_1ex10d2.htm EX-10.2 33362
4 EX-99.1 a10-21843_1ex99d1.htm EX-99.1 39628
5 GRAPHIC g218431mmi001.gif GRAPHIC 5356
6 GRAPHIC g218431mmi002.jpg GRAPHIC 2765
  Complete submission text file 0001104659-10-060202.txt   291734
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 101217334
SIC: 2834 Pharmaceutical Preparations